Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10976
CALL
Tenable Holdings
TENB
$4.36B
| $138K | ﹤0.01% |
3,500
-10,100
| -74% | -$419K |
2020 Q1
19 quarters
|
|
10977
PUT
Cambria Tail Risk ETF
TAIL
$148M
| $138K | ﹤0.01% |
12,300
+2,200
| +22% | +$25.3K |
2024 Q3
1 quarter
|
|
10978
PUT
AtriCure
ATRC
$2.69B
| $138K | ﹤0.01% |
4,500
-2,700
| -38% | -$86.8K |
2023 Q4
4 quarters
|
|
10979
PUT
Simmons First National
SFNC
$3.23B
| $138K | ﹤0.01% |
6,200
+5,600
| +933% | +$131K |
2023 Q1
7 quarters
|
|
10980
Aclaris Therapeutics
ACRS
$558M
| $137K | ﹤0.01% |
55,347
-309,220
| -85% | -$769K |
2020 Q3
17 quarters
|
|
|
FRGE
10981
DELISTED
Forge Global Holdings
FRGE
| $137K | ﹤0.01% |
9,808
-11,231
| -53% | -$185K |
2024 Q3
1 quarter
|
|
|
WSR
10982
DELISTED
Whitestone REIT
WSR
| $137K | ﹤0.01% |
+9,659
| New | +$138K |
2024 Q4
0 quarters
|
|
10983
PUT
Perimeter Solutions
PRM
$4.55B
| $137K | ﹤0.01% |
10,700
+6,300
| +143% | +$82.3K |
2022 Q4
8 quarters
|
|
|
ITOS
10984
CALL
DELISTED
iTeos Therapeutics
ITOS
| $137K | ﹤0.01% |
17,800
-14,300
| -45% | -$123K |
2022 Q2
10 quarters
|
|
|
AFMD
10985
DELISTED
Affimed
AFMD
| $137K | ﹤0.01% |
114,774
+107,959
| +1,584% | +$302K |
2024 Q3
1 quarter
|
|
10986
CALL
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.73B
| $137K | ﹤0.01% |
3,500
-15,000
| -81% | -$684K |
2020 Q3
17 quarters
|
|
10987
CALL
Opendoor
OPEN
$2.18B
| $136K | ﹤0.01% |
88,143
-422,324
| -83% | -$765K |
2020 Q3
17 quarters
|
|
10988
PUT
Immunic
IMUX
$101M
| $136K | ﹤0.01% |
13,630
+4,710
| +53% | +$59.3K |
2022 Q1
11 quarters
|
|
|
SCPH
10989
CALL
DELISTED
scPharmaceuticals
SCPH
| $136K | ﹤0.01% |
38,500
+18,000
| +88% | +$68.9K |
2022 Q3
9 quarters
|
|
10990
CALL
Star Holdings Shares of Beneficial Interest
STHO
$105M
| $136K | ﹤0.01% |
14,000
+13,500
| +2,700% | +$157K |
2023 Q2
6 quarters
|
|
10991
Kamada
KMDA
$446M
| $136K | ﹤0.01% |
22,363
-23,766
| -52% | -$136K |
2022 Q4
8 quarters
|
|
10992
PUT
Barnes & Noble Education
BNED
$404M
| $136K | ﹤0.01% |
+13,561
| New | +$139K |
2024 Q4
0 quarters
|
|
10993
CALL
Patria Investments
PAX
$1.85B
| $136K | ﹤0.01% |
11,700
-1,900
| -14% | -$22.4K |
2022 Q1
11 quarters
|
|
|
SOND
10994
CALL
DELISTED
Sonder
SOND
| $136K | ﹤0.01% |
42,785
-6,500
| -13% | -$23K |
2022 Q1
11 quarters
|
|
|
MITT
10995
TPG Mortgage Investment Trust
MITT
$178M
| $136K | ﹤0.01% |
20,440
-96,938
| -83% | -$686K |
2024 Q1
3 quarters
|
|
10996
CALL
WisdomTree India Earnings Fund ETF
EPI
$1.76B
| $136K | ﹤0.01% |
3,000
-8,000
| -73% | -$379K |
2016 Q3
33 quarters
|
|
10997
Energy Transfer Partners
ET
$70.8B
| $136K | ﹤0.01% |
6,922
-5,270,752
| -100% | -$93.3M |
2022 Q4
8 quarters
|
|
10998
CALL
Diamondrock Hospitality Co
DRH
$2.57B
| $135K | ﹤0.01% |
+15,000
| New | +$137K |
2024 Q4
0 quarters
|
|
10999
CALL
Sotera Health
SHC
$5.07B
| $135K | ﹤0.01% |
9,900
+5,000
| +102% | +$72.5K |
2021 Q3
13 quarters
|
|
11000
CALL
WaFd
WAFD
$2.19B
| $135K | ﹤0.01% |
4,200
-9,100
| -68% | -$320K |
2022 Q3
9 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.